Tag: News
Biotech & Life Sciences in China Update: Suzhou BioBay Announces New R&D Grants for Foreign Biotech Firms — Key Takeaways
Biotech in China Update: Suzhou BioBay Announces New R&D Grants for Foreign Firms — Key Takeaways Suzhou BioBay (苏州生物医药产业园, Sūzhōu shēngwù yīyào chǎny
Biotech & Life Sciences in China Update: China Expands Patent Linkage to Biologics — Key Takeaways
Biotech & Life Sciences in China Update: China Expands Patent Linkage to Biologics — Key Takeaways On April 15, 2025, the China National Drug Administ
Biotech & Life Sciences in China Update: CDE Launches Fast-Track IND Pilot for Gene Therapies — Key Takeaways
CDE Launches Fast-Track IND Pilot for Gene Therapies in China — Key Takeaways for Foreign Biotechs On April 1, 2025, the Center for Drug Evaluation (C
Biotech & Life Sciences in China Update: NMPA Reduces Drug Review Timelines to 120 Days — Key Takeaways
NMPA Reduces Drug Review Timelines to 120 Days — What This Means for Biotech in China In a landmark policy shift effective January 2025, China’s 国家药品监
China Cosmetics Update: NMPA Registration Backlog — Key Takeaways
China Cosmetics Update: NMPA Registration Backlog Reaches 35,000+ — What Brands Must Know As of Q4 2024, the National Medical Products Administration
China Beauty Update: Import Tariff Reductions — Key Takeaways
China Beauty Update: Import Tariff Reductions — Key Takeaways for Foreign Brands In a significant move to boost domestic consumption and high-end trad
